Key Financial Data Of Group

KYORIN Pharmaceutical Co., Ltd. - Filing #7373032

Concept As at
2023-09-30
2023-07-01 to
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-09-30
2022-07-01 to
2022-09-30
2022-04-01 to
2022-09-30
Key financial data of group
Business results of group
Net sales
54,937,000,000 JPY
113,270,000,000 JPY
49,093,000,000 JPY
Ordinary profit (loss)
1,387,000,000 JPY
5,827,000,000 JPY
1,171,000,000 JPY
Profit (loss) attributable to owners of parent
1,757,000,000 JPY
4,723,000,000 JPY
1,242,000,000 JPY
Comprehensive income
2,309,000,000 JPY
3,986,000,000 JPY
2,084,000,000 JPY
Net assets
126,226,000,000 JPY
125,461,000,000 JPY
124,735,000,000 JPY
Total assets
176,175,000,000 JPY
176,045,000,000 JPY
175,461,000,000 JPY
Basic earnings (loss) per share
18.85
30.66
82.44
1.04
21.69
Diluted earnings per share
Equity-to-asset ratio
0.716 xbrli:pure
0.713 xbrli:pure
0.711 xbrli:pure
Net cash provided by (used in) operating activities
8,364,000,000 JPY
2,008,000,000 JPY
6,218,000,000 JPY
Net cash provided by (used in) investing activities
327,000,000 JPY
-6,275,000,000 JPY
-3,707,000,000 JPY
Net cash provided by (used in) financing activities
-2,020,000,000 JPY
-3,363,000,000 JPY
-2,030,000,000 JPY
Cash and cash equivalents
25,584,000,000 JPY
18,816,000,000 JPY
27,001,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.